申请人:Lee Wen-Hwa
公开号:US20090221634A1
公开(公告)日:2009-09-03
Contemplated compounds disrupt interaction between BRCA2 and RAD51, likely by binding to RAD51. Based on the crucial role of the BRCA2-RAD51 complex formation in DNA repair and the role of RAD51 in the control of entry into S-phase from G1, numerous compositions and methods are presented. Among other advantageous uses, contemplated compounds may be employed as protective agents for non-neoplastic cells in chemotherapy before exposure of the cells to a chemotherapeutic drug, and/or as DNA-damage sensitizer for neoplastic cells.
考虑到化合物破坏BRCA2和RAD51之间的相互作用,可能是通过与RAD51结合实现的。基于BRCA2-RAD51复合物在DNA修复中的关键作用以及RAD51在从G1进入S期的控制中的作用,提出了许多组合物和方法。在其他有利的用途中,考虑到的化合物可以作为非肿瘤细胞在化疗之前的保护剂使用,以避免细胞暴露于化疗药物,并且可以作为肿瘤细胞的DNA损伤敏化剂。